RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 21 - per page Next page
Order by
Pharmalicensing Given Highest Rating by Argus Insights
Excellence Recognized for Pharmalicensing's Industry Information, Company and Technology Profiles, and Impressive Number of Deals Done More
TURKISH PATENT INSTITUTE ISSUES FIRST SULIDIN® (TOPICAL NIMESULIDE) PATENT: TR 2001 00455 B
Turkish patent office issues first Topical Nimesulide Patent for SULIDIN® under the title 'Nimesulide containing topical formulations'. More
APR has filed a new patent application for the preparation of stable aqueous dispersions of Hydrophobic substances, particularly Megestrol Acetate for the treatment of cachexia in patients with AIDS.
APR has patented a new process and technology for the preparation of granulates containing liposoluble and hydrphobic drugs, preferably Megestrol Acetate, which shows a rapid, stable water dispersibility without precipitation or flocculation. More
BIOVECTOR THERAPEUTICS REFOCUS ON ITS CORE BUSINESS
REORGANIZATION - FOCUS ON CORE BUSINESS More
Weston Medical Signs Intraject Manufacturing Agreement
Agreement with Patheon UK for the manufacture of Intraject, Weston Medical's lead product platform for needle-free injection of liquid drugs More
ForTe bv has developed several innovative OTC/Rx applications.
In addition to our current Pharmalicensing opportunities we are pleased to announce the successful development of several innovative application forms (OTC & Rx) with our (Patent Pending) Dry Suspension/Dispersion technology. More
New Pharmaceutical Plant for Focus Inhalation
A new plant for production of Taifun inhalers More
PA CONSULTING GROUP LAUNCHES NEW COMPANY - MERIDICA - TO MEET DEMANDS FOR DRUG DELIVERY TECHNOLOGY
PA Consulting Group, the leading management, systems and technology consulting firm, has launched a new company - Meridica - to harness its pharmaceutical and drug delivery technology expertise. More
An innovative new breath-actuated inhaler providing better asthma management completes first development phase
SkyePharma plc and Meridica Ltd, the new drug delivery company formed by PA Consulting Group, today announced the successful completion of the design and formulation stage for XceloventTM More
MacroMed, Inc. has entered into a multi-drug Evaluation and Option Agreement with Bristol-Myers Squibb Company
MacroMed and Bristol-Myers Squibb (BMS) have entered into a multi-drug Evaluation and Option Agreement allowing BMS access to MacroMed's proprietary solubilization technologies, HySolv(tm) and ReSolv(tm). More
Displaying 1..10 of 21 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Jun 2009 - 118 pages - $1,040
Who's Developing What in Drug Delivery 2009
Nov 2009 - 830 pages - $1,040
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Drug Delivery: Global Industry Guide
Dec 2006 - 90 pages - $995
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech
Nov 2010 - 428 pages - $2,695
Advances in the Transdermal Drug Delivery Market
Oct 2010 - 97 pages - $3,835
Drug Delivery: Heading Towards A Needle Free Future
May 2009 - 17 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us